Patents Assigned to Rheoxtech, LLC
-
Publication number: 20230098643Abstract: An interventional ostium occlusion catheter includes a catheter tube with at least one port at a first end, a tip at a second end, and a central lumen, with a positioning component and an occlusion component on the surface of the catheter tube close to the tip. A method of coronary intervention using the catheter includes maneuvering the catheter to an ostium; inserting the catheter into a coronary vessel; activating the positioning component and the occlusion component; and delivering an infusion via the lumen. An interventional system for improving management of ischemic cardiac tissue during acute coronary syndromes includes the catheter; a blood infusion device that delivers controlled reperfusate; and a ventricular unloading device that manipulates myocardial oxygen demand in a coronary chamber. The operator can mitigate reperfusion-related and oxygen-related tissue injury by precisely modulating oxygen re-exposure when re-establishing flow and when using a ventricular unloading device.Type: ApplicationFiled: September 28, 2022Publication date: March 30, 2023Applicant: Rheoxtech LLCInventors: Neil J. Thomas, Gintaras A. Vaisnys
-
Publication number: 20210113757Abstract: A system and methods are described for improving the management of ischemic cardiac tissue during acute coronary syndromes. The system combines a catheter-based sub-system which allows for simultaneous balloon dilation of a coronary artery and infusion of a carefully controlled perfusate during percutaneous coronary intervention. The system allows for modulation of levels of oxygen at the time of percutaneous intervention. In addition, catheters and systems are provided for administration of fluids with modified oxygen content during an intervention that incorporate upstream flow control members to compartmentalize the perfusion of the target coronary artery and the remainder of the heart.Type: ApplicationFiled: August 20, 2020Publication date: April 22, 2021Applicant: Rheoxtech LLCInventors: Neil J. Thomas, Gintaras A. Vaisnys
-
Patent number: 9775940Abstract: A system and methods are described for improving the management of ischemic cardiac tissue during acute coronary syndromes. The system combines a catheter-based sub-system which allows for simultaneous balloon dilation of a coronary artery and infusion of a carefully controlled perfusate during percutaneous coronary intervention. The system allows for modulation of levels of oxygen at the time of percutaneous intervention. In addition, catheters and systems are provided for administration of fluids with modified oxygen content during an intervention that incorporate upstream flow control members to compartmentalize the perfusion of the target coronary artery and the remainder of the heart.Type: GrantFiled: November 28, 2016Date of Patent: October 3, 2017Assignee: Rheoxtech, LLCInventors: Neil J. Thomas, Gintaras A. Vaisnys
-
Patent number: 9623167Abstract: A system and methods are described for improving the management of ischemic cardiac tissue during acute coronary syndromes or other ischemic conditions. A method and apparatus is described that allows mitigation of oxygen-related injury by precisely modulating the level of oxygen re-exposure during reoxygenation by a controlled feedback loop based on parameters of the tissue measured by a real-time tissue sensor or probe.Type: GrantFiled: October 27, 2014Date of Patent: April 18, 2017Assignee: RHEOXTECH, LLCInventors: Gintaras A. Vaisnys, Neil J. Thomas, James G. Moore
-
Patent number: 9504779Abstract: A system and methods are described for improving the management of ischemic cardiac tissue during acute coronary syndromes. The system combines a catheter-based sub-system which allows for simultaneous balloon dilation of a coronary artery and infusion of a carefully controlled perfusate during percutaneous coronary intervention. The system allows for modulation of levels of oxygen at the time of percutaneous intervention. In addition, catheters and systems are provided for administration of fluids with modified oxygen content during an intervention that incorporate upstream flow control members to compartmentalize the perfusion of the target coronary artery and the remainder of the heart.Type: GrantFiled: July 17, 2015Date of Patent: November 29, 2016Assignee: RHEOXTECH, LLCInventors: Neil J. Thomas, Gintaras A. Vaisnys
-
Patent number: 9211371Abstract: A method and apparatus for performing coronary perfusion and cardiac reoxygenation that enables accurate control of oxygen levels in blood used for the coronary circulation. Deoxygenated blood and oxygenated blood are collected and oxygen levels are measured by sensors. The deoxygenated and oxygenated blood is then mixed and the mixed blood is measured by another sensor. The sensors provide data used to provide real-time oxygen level measurement and adjustment for blood supplied for coronary circulation.Type: GrantFiled: April 29, 2014Date of Patent: December 15, 2015Assignee: Rheoxtech, LLCInventor: Neil J. Thomas
-
Patent number: 9084856Abstract: A system and methods are described for improving the management of ischemic cardiac tissue during acute coronary syndromes. The system combines a catheter-based sub-system which allows for simultaneous balloon dilation of a coronary artery and infusion of a carefully controlled perfusate during percutaneous coronary intervention. The system allows for modulation of levels of oxygen at the time of percutaneous intervention. In addition, catheters and systems are provided for administration of fluids with modified oxygen content during an intervention that incorporate upstream flow control members to compartmentalize the perfusion of the target coronary artery and the remainder of the heart.Type: GrantFiled: September 27, 2013Date of Patent: July 21, 2015Assignee: Rheoxtech, LLCInventors: Neil J. Thomas, Gintaras A. Vaisnys
-
Patent number: 8888737Abstract: A system and methods are described for improving the management of ischemic cardiac tissue during acute coronary syndromes or other ischemic conditions. A method and apparatus is described that allows mitigation of oxygen-related injury by precisely modulating the level of oxygen re-exposure during reoxygenation by a controlled feedback loop based on parameters of the tissue measured by a real-time tissue sensor or probe.Type: GrantFiled: October 20, 2009Date of Patent: November 18, 2014Assignee: Rheoxtech, LLCInventors: Gintaras A. Vaisnys, Neil J. Thomas, James G. Moore
-
Patent number: 8709343Abstract: A method and apparatus for performing coronary perfusion and cardiac reoxygenation that enables accurate control of oxygen levels in blood used for the coronary circulation. Deoxygenated blood and oxygenated blood are collected and oxygen levels are measured by sensors. The deoxygenated and oxygenated blood is then mixed and the mixed blood is measured by another sensor. The sensors provide data used to provide real-time oxygen level measurement and adjustment for blood supplied for coronary circulation.Type: GrantFiled: May 14, 2012Date of Patent: April 29, 2014Assignee: Rheoxtech, LLCInventor: Neil J. Thomas
-
Patent number: 8562585Abstract: A system and methods are described for improving the management of ischemic cardiac tissue during acute coronary syndromes. The system combines a catheter-based sub-system which allows for simultaneous balloon dilation of a coronary artery and infusion of a carefully controlled perfusate during percutaneous coronary intervention. The system allows for modulation of levels of oxygen at the time of percutaneous intervention. In addition, catheters and systems are provided for administration of fluids with modified oxygen content during an intervention that incorporate upstream flow control members to compartmentalize the perfusion of the target coronary artery and the remainder of the heart.Type: GrantFiled: July 17, 2009Date of Patent: October 22, 2013Assignee: Rheoxtech, LLCInventors: Neil J. Thomas, Gintaras A. Vaisnys
-
Publication number: 20130131638Abstract: A method and apparatus for performing coronary perfusion and cardiac reoxygenation that enables accurate control of oxygen levels in blood used for the coronary circulation. Deoxygenated blood and oxygenated blood are collected and oxygen levels are measured by sensors. The deoxygenated and oxygenated blood is then mixed and the mixed blood is measured by another sensor. The sensors provide data used to provide real-time oxygen level measurement and adjustment for blood supplied for coronary circulation.Type: ApplicationFiled: May 14, 2012Publication date: May 23, 2013Applicant: Rheoxtech, LLCInventor: Neil J. Thomas
-
Patent number: 8178041Abstract: A method and apparatus for performing coronary perfusion and cardiac reoxygenation that enables accurate control of oxygen levels in blood used for the coronary circulation. Deoxygenated blood and oxygenated blood are collected and oxygen levels are measured by sensors. The deoxygenated and oxygenated blood is then mixed and the mixed blood is measured by another sensor. The sensors provide data used to provide real-time oxygen level measurement and adjustment for blood supplied for coronary circulation.Type: GrantFiled: March 29, 2010Date of Patent: May 15, 2012Assignee: Rheoxtech, LLCInventor: Neil J. Thomas
-
Patent number: 7708942Abstract: A method and apparatus for performing coronary perfusion and cardiac reoxygenation that enables accurate control of oxygen levels in blood used for the coronary circulation. Deoxygenated blood and oxygenated blood are collected and oxygen levels are measured by sensors. The deoxygenated and oxygenated blood is then mixed and the mixed blood is measured by another sensor. The sensors provide data used to provide real-time oxygen level measurement and adjustment for blood supplied for coronary circulation.Type: GrantFiled: February 12, 2008Date of Patent: May 4, 2010Assignee: Rheoxtech, LLCInventor: Neil J. Thomas
-
Patent number: 7455812Abstract: A method and apparatus for performing coronary perfusion and cardiac reoxygenation that enables accurate control of oxygen levels in blood used for the coronary circulation. Deoxygenated blood and oxygenated blood are collected and oxygen levels are measured by sensors. The deoxygenated and oxygenated blood is then mixed and the mixed blood is measured by another sensor. The sensors provide data used to provide real-time oxygen level measurement and adjustment for blood supplied for coronary circulation.Type: GrantFiled: June 16, 2004Date of Patent: November 25, 2008Assignee: Rheoxtech, LLCInventor: Neil J. Thomas